Latest: FDA Approves New Biosimilar for Oncology Treatment

Don’t be fooled

0 Mins
Predatory journals and conference proceedings are flooding the scientific record. In my November 2017 editorial, “Fraud alert,” I described how the predatory journal explosion over the past few years had infiltrated the conference arena. Well colleagues, it’s worse now. Thinking of publishing an article or presenting at a conference, be aware of the dangers of...
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago